News
Bungwe lomenyera Ufulu wa anthu omwe ali ndi ulumali wosiyanasiyana la CHRR mongwirizana ndi bungwe loyang’anira mabungwe ena pa nkhaniyi, la MACODA likuchititsa mkumano wounikira anthuwa pa ...
LISBON—NDI has announced that Crestron has officially completed the NDI certification process for its 1 Beyond p-Series and i-Series cameras. This certification further demonstrates NDI’s growing ...
Ongoing phase 1/2 trial of the hematopoietic progenitor kinase 1 (HPK1) inhibitor NDI-101150 as monotherapy or in combination with pembrolizumab: Clinical safety and efficacy update in clear cell ...
President Donald Trump's Golden Dome missile defense system faces backlash from China, which has cited concerns over space militarization and urges the U.S. to halt its development.
Vizrt, known for its real-time graphics and live production tools, has brought to market a dedicated audio connectivity and monitoring technology product. Introducing Viz Connect Audio, which ...
About NDI-219216 NDI-219216 is a highly potent and selective non-covalent investigational inhibitor of Werner syndrome helicase (WRN) activity being developed for the treatment of MSI-H tumors.
Nimbus Therapeutics Announces Initiation of First-in-Human Clinical Trial with NDI-219216, Novel WRN Inhibitor for MSI-H Tumors – First participants dosed in Phase 1/2 clinical trial ...
AFSC sponsors employee resource groups (ERGs) for women, parents, young professionals and seasoned professionals. The groups organize different activities, including bringing in outside speakers.
PUTRAJAYA: In an effort to create a more meaningful measurement of poverty rate in Malaysia, the concept of net disposable income (NDI) will be used as the basis for identifying groups who ...
Corsha Inc. lands SBIR Phase III contract for M2M security, enhancing ATO certifications and bolstering AFSC's OT cybersecurity and innovation. Discover pioneering solutions for Industry 4.0.
3083Background: NDI-101150 is a potent, selective, oral inhibitor of hematopoietic progenitor kinase 1 (HPK1), with a different immunotherapy mechanism to other checkpoint inhibitors. NDI-101150 ...
Despite having recently lost out to its E-7 rival for NATO's iAFSC requirement, Saab sees a strong future for its GlobalEye (pictured) platform as part of the alliance's wider AFSC structure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results